Core Viewpoint - Lin Qingxuan, known as the "first stock of high-end domestic skincare," is expected to be included in the Hong Kong Stock Connect list on March 9, which will enhance its liquidity and market attention, broadening its financing channels [1]. Group 1: Company Overview - Lin Qingxuan officially listed on the Hong Kong Stock Exchange on December 30, 2025, with an initial offering price of HKD 77.77 per share, closing at HKD 90.45 two days later, marking a rise of over 16% and a market capitalization exceeding HKD 12.6 billion [4]. - The company focuses on providing high-end skincare solutions using natural camellia oil ingredients, ranking first among domestic high-end skincare brands in China and being the only domestic representative among the top 15 high-end skincare brands [4]. - Lin Qingxuan has established itself as a pioneer in the "oil-based skincare" segment, with its flagship product, camellia oil essence, achieving cumulative sales of over 50 million bottles by the end of 2025, maintaining the top position in the national facial essence oil category for 11 consecutive years [4]. Group 2: Product Performance - The camellia oil essence has undergone five iterations, now positioned as a "cell-level" anti-wrinkle essence, with comprehensive upgrades in efficacy, ingredients, technology, and packaging [4]. - New products launched in recent years have quickly gained market validation, contributing to the company's growth trajectory [4]. - For instance, the camellia anti-wrinkle peptide microbead essence water achieved over HKD 7 million in GMV on its first day and surpassed HKD 260 million in cumulative GMV within three months [5]. - The black gold anti-wrinkle brightening essence cream generated revenue of HKD 61.5 million in its first year and HKD 50 million in the first half of 2025, while the high SPF sunscreen achieved sales of HKD 36.3 million in its debut year, with a significant increase to HKD 42.1 million in the first half of 2025 [5].
LiveReport大数据预测林清轩3月入通 公司新品上市不足半年销售额破2.6亿